Host: Matt Birnholz, MD

Guest: Javier Morales, MD, FACP, FACE

Guest: Wendy S. Lane, MD

Demonstration and Panel Discussion: We will present video demonstrations of how to administer fixed-ratio combinations of GLP-1 receptor agonists and basal insulin, accompanied by a panel discussion with Drs. Lane and Morales on strategies for overcoming barriers to injectable therapy for type 2 diabetes.

Host: William J. Fredette, Jr., MD, FAAP

Guest: John J. Russell, MD

The ACIP immunization schedule for adolescents now includes recommended vaccination for human Papillomavirus (HPV)-associated cancers, meningococcal disease, influenza, and pertussis, in addition to vaccines for certain-high risk groups and those who require catch-up vaccination. However, a 2014 National Immunizations Survey reveals that vaccination uptake for HPV and for meningococcal disease is falling short of levels seen for many other vaccines, especially in females. Today’s discussion addresses these issues as well as the sources of resistance to HPV and meningococcal disease immunization; and delves into system and provider strategies for increasing the overall uptake of vaccination by adolescents.

CME credits: 0.25

Valid until: 08-05-2019

Claim your CME credit at https://reachmd.com/programs/cme/addressing-fibromyalgia-timely-diagnosis-individualizing-treatment/9528/

Fibromyalgia is a common disorder characterized by widespread chronic pain, fatigue, sleep disturbances, headaches, and cognitive impairment, which may fluctuate in intensity. Symptoms of fibromyalgia overlap many other conditions, which may complicate its diagnosis.

Host: Matt Birnholz, MD

Guest: Cynthia Gyamfi-Bannerman, MD, BSc, MSc

With ACOG changing the definition of preterm birth and the available efficacy and safety data for current progestogen agents, preterm birth is a quickly advancing field for practicing physicians to effectively manage. This activity will discuss the risks and benefits of to the clinical management of women at risk for preterm birth and the redefinition of “term pregnancy”. Join Dr. Cynthia Gyamfi-Bannerman while she discusses clinical management of women at-risk for spontaneous preterm birth. In January 2017, after the original release of this activity, The Society for Maternal Fetal Medicine Publications Committee made public an SMFM Statement entitled: The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth. Click here to access this article.

Host: Matt Birnholz, MD

Several new screening tests have been developed to help doctors find colorectal cancer early when it's most treatable and can reduce the burden of this disease and the death toll nationwide. Host Dr. Matt Birnholz chats with Dr. John Kisiel, gastroenterologist and Assistant Professor of Medicine at Mayo Clinic College of Medicine, about new screening guidelines for detecting colorectal cancer.

Guest: Anthony J. Lembo, MD

Guest: Michael J. Brennan, MD

Guest: April M. Zehm, MD

As the United States population ages, an increasing number of individuals will suffer from significant pain as they approach end of life.1 Despite advances in our understanding of pain physiology and available treatment modalities, pain associated with life-threatening illnesses is often untreated or undertreated.2 This results in part from side effects of commonly prescribed analgesics. For example, opioids have long been the cornerstone treatment for pain associated with cancer or other terminal conditions.3,4 The most frequent side effect of prescription opioids is constipation, which ranks as the third most commonly reported symptom in palliative care.5,6 Unaddressed opioid-induced constipation (OIC) can have markedly deleterious effects on patient function and quality of life.7,8 With an overall goal of improving comprehensive pain management in patients receiving palliative care, this Evidence-Based Best Practices program will examine the pathophysiology of opioid-induced bowel dysfunction, prophylactic treatment regimens for OIC, assessment strategies to identify and monitor affected patients, and new therapeutic approaches that mitigate OIC effectively and safely. References Robinson CL. Health Prog. 2007;88(1):48-53. Deandrea S, et al. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985-1991. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 2.2016. American ...

Guest: Emma Guttman-Yassky, MD, PhD

Atopic dermatitis (AD) is the most common and relapsing allergic disease of the skin. Atopic dermatitis (or atopic eczema) is an inflammatory skin condition characterized by pruritis, and often occurring in the skin flexures. The prevalence rate for atopic dermatitis is estimated at up to 25% in children and 2%-3% adults. The diagnosis and management of patients with atopic dermatitis presents challenges along the course of the disease. New findings from scientific research as to the pathophysiology of AD is redefining strategies for its therapeutic management.

Guest: Donald Y. Leung, MD, PhD

Atopic dermatitis (AD) is the most common and relapsing allergic disease of the skin. Atopic dermatitis (or atopic eczema) is an inflammatory skin condition characterized by pruritis, and often occurring in the skin flexures. The prevalence rate for atopic dermatitis is estimated at up to 25% in children and 2%-3% adults. The diagnosis and management of patients with atopic dermatitis presents challenges along the course of the disease. New findings from scientific research as to the pathophysiology of AD is redefining strategies for its therapeutic management.

Guest: Mark A. Socinski, MD

Discussions will focus on the angiogenesis pathway in NSCLC, the implementation of vascular endothelial growth factor (VEGF) inhibitors in older patients with NSCLC and its controversies, clinical results with use of VEGF inhibitors in older patients, and factors causing unintended treatment bias. An expert thought leader will provide insights in support of their perspectives on the discussion points. This activity is based upon outcomes from a prior predictive modeling analysis of a live grand rounds series, and features evidence-based updates and expert consensus recommendations to address specific educational gaps highlighted as a result of the predictive modeling exercise. The activity focused on the drivers identified that influence poor performance, and provides the evidence to assist learners in overcoming said drivers and gaps, apply this information to clinical situations, and encourage steps to close these remaining gaps in their own practices.

Guest: William J. Sandborn, MD

IBD is a chronic gastrointestinal condition characterized by recurring disease activity. Treatment approaches for IBD vary depending on disease type and severity and patient risk profile. An accurate diagnosis combined with severity and risk assessments at appropriate intervals are essential for optimal management of IBD. Despite guidance from AGA and ACG, however, clinicians demonstrate considerable variation in their approaches to both risk assessment and care for patients with IBD. This activity will address severity and risk assessment, appropriate treatment, and patient communication.